Cargando…
Nuclease-Mediated Gene Therapies for Inherited Metabolic Diseases of the Liver
Inherited metabolic diseases (IMDs) of the liver represent a vast and diverse group of rare genetic diseases characterized by the loss or dysfunction of enzymes or proteins essential for metabolic pathways in the liver. Conventional gene therapy involving adeno-associated virus (AAV) serotype 8 vect...
Autores principales: | Bryson, Taylor E., Anglin, Caitlin M., Bridges, P. Hudson, Cottle, Renee N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733857/ https://www.ncbi.nlm.nih.gov/pubmed/29259521 |
Ejemplares similares
-
Gene Therapy for Inherited Metabolic Diseases
por: Yilmaz, Berna Seker, et al.
Publicado: (2020) -
Delivery Approaches for Therapeutic Genome Editing and Challenges
por: Ates, Ilayda, et al.
Publicado: (2020) -
Liver transplantation for pediatric inherited metabolic liver diseases
por: Vimalesvaran, Sunitha, et al.
Publicado: (2021) -
Transposon-encoded nucleases use guide RNAs to selfishly bias their inheritance
por: Meers, Chance, et al.
Publicado: (2023) -
Gene therapy for inherited retinal diseases
por: Nuzbrokh, Yan, et al.
Publicado: (2021)